PEStore

Venture Capital

Jumpstart Nova

Jumpstart Nova backs early-stage and high-growth companies, typically pre-profit, from Nashville, USA. It states a focus on healthcare & life sciences and software & internet.

Capital raised$71macross 2 SEC-filed vehicles
Most recent fund2024filing since 2020
HeadquartersNashville, USA
Largest single fund$55m

SEC filings

What Jumpstart Nova has raised

From this firm's own Form D filings. A fund files one within fifteen days of its first sale, under penalty of perjury, which makes these the hardest numbers on the page.

Vehicles filed2
Total capital raised$71m
Largest single vehicle$55m
Filing history2020 to 2024
Smallest accepted commitment$100k
Filed fromTENNESSEE

Form D covers US-domiciled vehicles raised from accredited investors. It will not capture a fund raised outside the United States, separately managed accounts, or capital deployed off balance sheet, so treat these as a floor rather than a total.

Regulatory record

How Jumpstart Nova is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised17 · $140m gross
SEC adviser numberCRD 309720

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies Jumpstart Nova lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Alerje
Feno
Health Cost IQ
Intus Care
Jumpstart Capital
Jumpstart Foundry
Jumpstart Insight
Jumpstarthealth
Mae
SoHookd
Teamwork Healthcare
Teamworkcares
Therify
Time Study

Compiled from Jumpstart Nova’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this Jumpstart Nova?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.